文献速递主动脉外科

使用冰冻象鼻支架装置行全主动脉弓置换:美国多中心试验1年结果

Total aortic arch replacement using a frozen elephant trunk device: Results of a 1-year US multicenter trial.
PubMed 文献 · J Thorac Cardiovasc Surg · 2022-09-06

本前瞻性美国研究性器械豁免试验纳入12个中心的65例非破裂患者和9例破裂患者,评估Thoraflex Hybrid装置行冰冻象鼻技术修复升主动脉、主动脉弓和降胸主动脉的安全性和1年临床结局。主要终点为主要不良事件(MAE)免于发生,非破裂组1年免于MAE为81%(51/63),破裂组为71%(5/7)。作者认为1年结果可接受,需长期数据评估耐久性。

要点

  • 非破裂组1年免于MAE为81%(51/63),破裂组为71%(5/7)。
  • 非破裂组死亡7例(11%),永久性卒中3例(5%),永久性截瘫/轻截瘫3例(5%)。
  • 破裂组死亡1例(14%),永久性卒中2例(29%),无永久性截瘫/轻截瘫。

核心结论

  • Thoraflex Hybrid装置的1年结果可接受。
  • 需要长期数据评估这些修复的耐久性。

研究设计与样本

  • 前瞻性美国研究性器械豁免试验,涉及12个美国中心。
  • 非破裂患者65例纳入主要研究组,破裂患者9例纳入破裂组。
  • 所有患者均因动脉瘤和/或夹层接受升主动脉、主动脉弓和降胸主动脉开放手术修复。
  • 主要终点为主要不良事件(MAE)免于发生,定义为永久性卒中、永久性截瘫/轻截瘫、非预期主动脉相关再手术(排除出血再手术)或全因死亡。

主要发现

  • 主要研究组1年时2例失访,1年免于MAE为81%(51/63)。
  • 主要研究组7例(11%)死亡(包括2例在30天或出院前),3例(5%)发生永久性卒中,3例(5%)发生永久性截瘫/轻截瘫。
  • 主要研究组26例(41%)接受计划性延伸手术,包括22例血管内手术,中位时间122天(四分位距64-156天)。
  • 破裂组1年时2例失访,1年免于MAE为71%(5/7)。
  • 破裂组1例(14%)死亡,2例(29%)发生永久性卒中,无永久性截瘫/轻截瘫;破裂组未行延伸手术。

局限性

  • 需要长期数据评估这些修复的耐久性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In this prospective US investigational device exemption trial, we assessed the safety and 1-year clinical outcomes of the Thoraflex Hybrid device (Terumo Aortic) for the frozen elephant trunk technique to repair the ascending aorta, aortic arch, and descending thoracic aorta. METHODS: For the trial, which involved 12 US sites, 65 patients without rupture were recruited into the primary study group, and 9 patients were recruited into the rupture group. All patients underwent open surgical repair of the ascending aorta, aortic arch, and descending thoracic aorta in cases of aneurysm and/or dissection. The primary end point was freedom from major adverse events (MAE), defined as permanent stroke, permanent paraplegia/paraparesis, unanticipated aortic-related reoperation (excluding reoperation for bleeding), or all-cause mortality. RESULTS: In the primary study group, 2 patients were lost to follow-up at 1 year. Freedom from MAE at 1 year was 81% (51/63). Seven patients (11%) died (including 2 before 30 days or discharge), 3 patients (5%) suffered permanent stroke, and 3 (5%) developed permanent paraplegia/paraparesis. Twenty-six patients (41%) underwent planned extension procedures, including 22 endovascular procedures within a median of 122 (interquartile range, 64-156) days. In the aortic rupture group, 2 patients were lost to follow-up at 1 year. Freedom from MAE at 1 year was 71% (5/7). One patient (14%) died, 2 patients (29%) had permanent stroke, and none had permanent paraplegia/paraparesis. No extension procedures were performed in the rupture group. CONCLUSIONS: One-year results with the Thoraflex Hybrid device are acceptable. Long-term data are necessary to assess the durability of these repairs.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Coselli JS, Roselli EE, Preventza O, et al. Total aortic arch replacement using a frozen elephant trunk device: Results of a 1-year US multicenter trial. J Thorac Cardiovasc Surg. 2022. PMID: 36253292. doi:10.1016/j.jtcvs.2022.08.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。